Accueil > Actualité
Actualite financiere : Actualite bourse

Pfizer: tightens up target ranges for 2020

(CercleFinance.com) - Pfizer has tightened up its target adjusted EPS range for 2020, now aiming for 2.
88-2.93 dollars, instead of 2.85-2.95 dollars, with sales of 48.8-49.5 billion dollars, against 48.6-50.6 billion dollars forecast previously.

In Q3 2020, the healthcare giant saw its adjusted net profit slip 3% to 4.07 billion dollars, or 72 cents per share, representing EPS that is broadly in line with expectations, with revenues down 4% to just over 12.1 billion dollars.

In operational terms, revenues were also down 4%, albeit with 4% growth at its biopharma division, thanks to Vyndaqel and biosimilars, although this was offset by an 18% decline in the Upjohn division, which suffered from the loss of exclusivity on Lyrica in the US in 2019.


Copyright (c) 2020 CercleFinance.com. All rights reserved.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.